trending Market Intelligence /marketintelligence/en/news-insights/trending/f13szcvvsqiqdmbaaz-xcw2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

BioSig implementing 1-for-2.5 reverse stock split for Nasdaq uplisting

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


BioSig implementing 1-for-2.5 reverse stock split for Nasdaq uplisting

BioSig Technologies Inc. said it will implement a 1-for-2.5 reverse split of its common stock after the close of business Sept. 10 to meet requirements for its Nasdaq uplisting.

The Los Angeles-based development stage medical device company said its stock will begin trading on a split-adjusted basis from Sept. 11.

The reverse split was approved by BioSig's stockholders July 30.

BioSig's first product, the PURE EP System, which records and calculates electrocardiographic and intracardiac signals, among other things, for patients undergoing electrophysiology procedures in a laboratory, was approved by the U.S. Food and Drug Administration in August.